Search filters

List of works by Marco Galluzzo

<i>HLA-Cw6</i> and other HLA-C alleles, as well as <i>MICB-DT, DDX58</i> and <i>TYK2</i> genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis

scientific article published on 09 December 2020

A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab

scientific article published on 26 September 2018

A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab

scientific article published on 30 May 2020

A safety evaluation of guselkumab for the treatment of psoriasis

scientific article published on 04 July 2018

Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients.

scientific article

Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis.

scientific article

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature

scientific article published on 29 April 2019

Brodalumab for the treatment of psoriasis

scientific article

Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic: Risk Analysis from the PSO-BIO-COVID Observational Study

scientific article published on 20 November 2020

Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature

scientific article published on 17 February 2020

Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients

scientific article

Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study

scientific article published on 4 January 2018

Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessm

scholarly article by Mario Puviani et al published 20 September 2018 in International Journal of STD & AIDS

Genetic variations in IL6 and IL12B decreasing the risk for psoriasis.

scientific article published on 17 October 2013

HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up.

scientific article published in February 2016

HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study

scientific article published on 28 January 2017

HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis

scientific article published on April 2016

High-resolution HLA typing identifies a new 'super responder' subgroup of HLA-C*06:02-positive psoriatic patients: HLA-C*06:02/HLA-C*04, in response to ustekinumab

scientific article published on 20 May 2019

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.

scientific article published on 18 December 2015

Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studies

scientific article published on 27 November 2020

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

scientific article published on 27 December 2019

Linear psoriasis following the typical distribution of the sciatic nerve.

scientific article

Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature

scientific article

Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

scientific article published on 30 March 2013

New insight into the pathogenesis of nail psoriasis and overview of treatment strategies

scientific article published on 30 August 2017

Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

article

Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis

scientific article

Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections

scientific article published on 20 December 2017

Pharmacotherapeutic management of psoriasis in adolescents and children

scientific article published on 04 July 2019

Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study

scientific article published on 01 June 2018

Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab

article

Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers

scientific article published on 01 April 2020

Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients.

scientific article published on 16 February 2017

Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation

scientific article published on 06 June 2018

Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo

scientific article published on 05 January 2020

Skin immunity and its dysregulation in psoriasis

scientific article published on 15 August 2019

Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date

article

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

scientific article published on 08 June 2020

Successful treatment of psoriatic crumbly nails with ustekinumab

scientific article published on 21 April 2019

The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

scientific article

The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis

scientific article published on 11 September 2019

Tildrakizumab for treating psoriasis.

scientific article published on 8 March 2017

Tofacitinib for the treatment of psoriasis

scientific article

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy

scientific article published on 01 December 2018

Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study

scientific article published on 09 July 2020

Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience

scientific article published on 30 October 2019

Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.

scientific article published on 26 September 2013

What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice.

scientific article

Paulina is supported by:

About Paulina

Help